Fred Brown

Q: What Schools Are Affiliated With Fred Brown

Fred Brown is affiliated with the following schools: Queen's University Belfast, Imperial College London, University of Bristol, University of Oxford, Purdue University, University of Manchester

Fred Brown 's AcademicInfluence.com Rankings

Fred Brown

Biology

#4386

World Rank

#6546

Historical Rank

Virology

#109

World Rank

#113

Historical Rank

biology Degrees

Download Badge

Biology

Fred Brown 's Degrees

Bachelors Microbiology University of Manchester
PhD Virology University of Oxford

Why Is Fred Brown Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Fred Brown was a British virologist and molecular biologist. Early life He was born in Clayton-le-Moors, Lancashire and lived in neighbouring Burnley, where he was educated at Burnley Grammar School and played cricket for Burnley Cricket Club. He went on to study at Manchester University, where he graduated B.Sc. in chemistry in 1944 and received a Ph.D. in 1946.

(See a Problem?)

Fred Brown 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution (1989) (832)
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence (1982) (795)
Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. (2003) (480)
Myristylation of picornavirus capsid protein VP4 and its structural significance (1987) (450)
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). (1989) (408)
Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. (2002) (372)
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein (1987) (326)
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. (1984) (286)
Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants (1987) (219)
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus (1990) (209)
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice (1993) (182)
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK (1981) (175)
Chemical basis of antigenic variation in foot-and-mouth disease virus (1983) (171)
Classification of Rhabdovirus Proteins: a Proposal (1972) (168)
The Classification and Nomenclature of Viruses: Summary of Results of Meetings of the International Committee on Taxonomy of Viruses in Sendai, September 1984 (1986) (156)
The Family Rhabdoviridae (1987) (149)
Effective synthetic peptide vaccine for foot-and-mouth disease in swine. (2002) (143)
New approaches to vaccination against foot-and-mouth disease. (1992) (142)
A Foot and Mouth Disease Syndrome in Pigs caused by an Enterovirus (1968) (129)
Purification of Radioactive Foot-and-Mouth Disease Virus (1963) (128)
Presence of a covalently linked protein on calicivirus RNA. (1978) (123)
Surface structure of foot-and-mouth disease virus. (1969) (123)
Protein covalently linked to foot-and-mouth disease virus RNA (1977) (122)
The history of research in foot-and-mouth disease. (2003) (117)
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. (1999) (116)
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus. (1975) (114)
Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. (1991) (112)
A physico-chemical sub-grouping of the mammalian picornaviruses. (1973) (110)
Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. (1993) (108)
Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. (1995) (107)
Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. (1989) (105)
Immune response to uncoupled peptides of foot-and-mouth disease virus. (1987) (104)
Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. (1989) (96)
The proteins of biologically active sub-units of vesicular stomatitis virus. (1970) (95)
Surface structure of vesicular stomatitis virus. (1969) (94)
Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. (1989) (92)
Immunological priming with synthetic peptides of foot-and-mouth disease virus. (1985) (92)
Host cell selection of antigenic variants of foot-and-mouth disease virus. (1989) (90)
Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. (1979) (90)
Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals. (1987) (84)
Serological relationships between different strains of vesicular stomatis virus. (1972) (82)
Antigenic Differences between Isolates of Swine Vesicular Disease Virus and their Relationship to Coxsackie B5 Virus (1973) (79)
A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. (1997) (78)
Molecular approaches to the control of infectious diseases (1995) (77)
Heterogeneity of the genome-linked protein of foot-and-mouth disease virus (1980) (76)
Relationship of a virus from Tellina tenuis to infectious pancreatic necrosis virus. (1977) (75)
Further evidence for multiple proteins in the foot-and-mouth disease virus particle. (1971) (75)
Review of accidents caused by incomplete inactivation of viruses. (1993) (73)
Nature of the inactivating action of trypsin on foot-and-mouth disease virus. (1967) (72)
Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. (1977) (72)
Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. (1959) (71)
Immunological properties of hepatitis B core antigen fusion proteins. (1990) (69)
Oligonucleotide mapping of picornavirus RNAs by two-dimensional electrophoresis. (1976) (66)
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. (1979) (63)
A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. (2003) (62)
Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA (1980) (61)
Evidence for a Divided Genome in Nodamura Virus, an Arthropod-borne Picornavirus (1973) (60)
Model for Vesicular Stomatitis Virus (1972) (60)
Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. (1990) (59)
Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria. (1990) (58)
Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide. (1977) (58)
Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components. (1970) (57)
The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus. (1967) (55)
More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA (1978) (55)
Purification of the Virus of Foot-and-Mouth Disease by Fluorocarbon Treatment and Its Dissociation from Neutralizing Antibody (1960) (55)
Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection. (1971) (54)
Antibody recognition and neutralization of foot-and-mouth disease virus (1995) (54)
Dissociation of Foot-and-Mouth Disease Virus into its Nucleic Acid and Protein Components (1961) (54)
Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. (1997) (54)
The structure and replication of calicivirus RNA (1978) (54)
The use of acetylethyleneimine in the production of inactivated foot-and-mouth disease vaccines (1963) (53)
Demonstration of three specific sites on the surface of foot-and-mouth disease virus by antibody complexing. (1970) (53)
Recombinant vaccinia viruses as vaccines (1986) (53)
Buoyant density of picornaviruses in caesium salts. (1971) (51)
3′-Terminal nucleotide sequences in the genome RNA of picornaviruses (1978) (51)
Comparison of bluetongue type 20 with certain viruses of the bluetongue and Eubenangee serological groups of orbiviruses. (1981) (50)
Sequence and location of the poly C tract in aphtho- and cardiovirus RNA. (1979) (50)
Further physicochemical characterization of Nodamura virus. Evidence that the divided genome occurs in a single component. (1978) (49)
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes (1981) (49)
Foot-and-mouth disease virus particles contain replicase protein 3D. (1994) (48)
Comparative virology of the small RNA viruses. (1973) (48)
Biochemical mapping of the foot-and-mouth disease virus genome. (1977) (48)
Evidence for a group protein in foot-and-mouth disease virus particles. (1973) (46)
Viral capsid mobility: A dynamic conduit for inactivation (2001) (46)
Absence of poly (A) from the infective RNA of Nodamura virus. (1976) (45)
Inactivation of viruses by aziridines. (2001) (45)
Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals. (1986) (44)
Evidence for the persistence of foot-and-mouth disease virus in pigs. (1999) (44)
The classification and nomenclature of viruses: summary of results of meetings of the International Committee on Taxonomy of Viruses in Edmonton, Canada 1987. (1989) (43)
An assessment by competition hybridization of the sequence homology between the RNAs of the seven serotypes of FMDV. (1977) (43)
Physico-chemical evidence for the re-classification of the caliciviruses. (1974) (42)
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. (1978) (41)
Vaccines 85 : molecular and chemical basis of resistance to parasitic, bacterial, and viral diseases (1985) (41)
Structural dynamics, an intrinsic property of viral capsids (2001) (41)
A model for foot-and-mouth disease virus. (1972) (41)
Comparative biochemical and serological analysis of five isolates of a single serotype of foot-and-mouth disease virus. (1979) (41)
Infectivity of Ribonucleic Acid from Mice and Tissue Culture infected with the Virus of Foot-and-Mouth Disease (1958) (41)
Broad‐spectrum virus reduction in red cell concentrates using INACTINE™ PEN110 chemistry (2002) (41)
A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. (1987) (40)
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. (1979) (39)
Application of agar gel precipitin tests to the study of the virus of foot-and-mouth disease. (1958) (39)
Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals. (1996) (38)
Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. (1980) (38)
The effect of various inactivating agents on the viral and ribonucleic acid infectivities of foot-and-mouth disease virus and on its attachment to susceptible cells. (1963) (38)
Effect of vesicular stomatitis virus and Semliki Forest Virus on uptake of nutrients and intracellular cation concentration. (1983) (38)
Expression in Yeast of Amino-Terminal Peptide Fusions to Hepatitis B Core Antigen and Their Immunological Properties (1990) (38)
A New Model for Virus Ribonucleic Acid Replication (1965) (36)
Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex (1997) (36)
The physico-chemical characterization of bovine ephemeral fever virus as a member of the family Rhabdoviridae. (1979) (36)
Use of peptides for immunization against foot-and-mouth disease. (1988) (36)
Characterization of the minor polypeptides in the foot-and-mouth disease particle. (1976) (35)
Serological prospects for peptide vaccines against foot-and-mouth disease virus. (1989) (35)
Correlations between the conformations elucidated by CD spectroscopy and the antigenic properties of four peptides of the foot-and-mouth disease virus. (1991) (34)
Correlation of polypeptide composition with antigenic variation in the swine vesicular disease and coxsackie B5 viruses (1975) (34)
An interfering component of rabies virus which contains RNA. (1974) (33)
Studies with infective ribonucleic acid from tissues and cell cultures infected with the virus of foot-and-mouth disease. (1959) (33)
Variation in the coxsackievirus type B5 and its possible role in the etiology of swine vesicular disease. (1974) (33)
FURTHER STUDIES OF THE EARLY ANTIBODY IN THE SEA OF CATTLE AND GUINEA PIGS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS. (1964) (33)
Comparison of swine vesicular disease virus and Coxsackie B5 virus by serological and RNA hybridization methods. (1976) (33)
West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation (2003) (33)
Control of Wildlife Rabies (1985) (32)
The Location of the Poly(C) Tract in the RNA of Foot-and-Mouth Disease Virus (1976) (32)
A model for vesicular exanthema virus, the prototype of the calicivirus group. (1978) (32)
The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components. (1966) (32)
In vitro measurement of the potency of inactivated foot-and-mouth disease virus vaccines (1963) (32)
Viral Subunits for Rabies Vaccination (1969) (32)
The structure of foot-and-mouth disease virus: implications for its physical and biological properties. (1990) (31)
Physicochemical and serological characterization of two rhabdoviruses isolated from eels. (1980) (31)
Characterization of an acid-resistant mutant of foot-and-mouth disease virus. (1995) (31)
Early events in the interaction between foot-and mouth disease virus and primary pig kidney cells. (1978) (31)
Purification and physicochemical characteristics of African swine fever virus. (1976) (30)
Reactions between an Insect Picornavirus and Naturally Occurring IgM Antibodies in Several Mammalian Species (1973) (29)
Encephalomyocarditis virus antibodies in sera from apparently normal pigs (1977) (28)
Evidence for an internal antigen in foot-and-mouth disease virus. (1969) (28)
Application of RNase T1 one- and two-dimensional analyses to the rapid identification of foot-and-mouth disease viruses (1982) (28)
Infective Virus Substructure from Vesicular Stomatitis Virus (1967) (28)
Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. (1995) (28)
A high density component in several vertebrate enteroviruses. (1975) (27)
Intranasal Immunization of Guinea Pigs with an Immunodominant Foot-and-Mouth Disease Virus Peptide Conjugate Induces Mucosal and Humoral Antibodies and Protection against Challenge (2003) (27)
Virus Specific Ribonucleic Acids in Baby Hamster Kidney Cells Infected With Foot-and-Mouth Disease Virus (1964) (26)
Stabilising oral poliovaccine at high ambient temperatures. (1996) (26)
Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses. (1977) (26)
Molecular weight of rhinovirus ribonucleic acid. (1970) (26)
The effect of heat on the structure of foot-and-mouth disease virus and the viral ribonucleic acid. (1966) (26)
Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. (1982) (25)
A CD strategy for the study of polypeptide folding/unfolding. A synthetic foot-and-mouth disease virus immunogenic peptide. (2009) (25)
The antigens of vesicular stomatitis virus. 3. Structure and immunogenicity of antigens derived from the virion by treatment with Tween and ether. (1967) (25)
Crystallization and preliminary X-ray diffraction analysis of foot-and-mouth disease virus. (1987) (25)
Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide. (1999) (24)
Biochemical aspects of variation in foot-and-mouth disease virus. (1980) (24)
The potential of retro-inverso peptides as synthetic vaccines. (1998) (24)
Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines. (1995) (24)
Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. (1999) (24)
Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus. (1997) (24)
Isolation of a soluble and template-dependent foot-and-mouth disease virus RNA polymerase. (1981) (24)
Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera. (1981) (23)
Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate (1981) (23)
Surface structure and RNA-protein interactions of foot-and-mouth disease virus. (1987) (23)
A study of the kinetics of protein and RNA synthesis induced by foot-and-mouth disease virus. (1966) (23)
Glycolipid nature of the complement-fixing host cell antigen of vesicular stomatitis virus. (1972) (22)
Relationship of San Miguel sea lion virus to other members of the calicivirus group. (1978) (22)
Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines. (2000) (22)
Lipid and protein organization in vesicular stomatitis and Sindbis viruses. (1974) (22)
Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. (1978) (22)
Role of sialic acid in infection with vesicular stomatitis virus. (1977) (21)
Synthetic peptide-based vaccine and diagnostic system for effective control of FMD. (2001) (21)
Chemically synthesized peptides elicit neutralizing antibody to bovine enterovirus. (1990) (21)
Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins. (1998) (21)
Interfering Component of Vesicular Stomatitis Virus (1966) (21)
Specific Precipitin Reactions with the Viruses of Foot-and-Mouth Disease and Vesicular Stomatitis (1957) (20)
Inhibitors of RT-PCR in serum. (2000) (20)
Temperature-sensitive RNA polymerase mutants of a picornavirus. (1981) (20)
Characterization of Theiler's murine encephalomyelitis virus RNA. (1982) (20)
Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions (1996) (20)
Synthetic peptides mimic subtype specificity of foot‐and‐mouth disease virus (1983) (20)
Physicochemical characterization of two serologically unrelated equine rhinoviruses. (1977) (19)
Reaction of Glutaraldehyde with Foot-and-Mouth Disease Virus (1973) (19)
Further studies on the infection of pig-kidney cells by foot-and-mouth disease virus. (1962) (19)
Interference as a measure of cross-relationships in the vesicular stomatitis group of rhabdo viruses. (1973) (19)
Quality of biotechnological products : Stability testing of biotechnological/ biological products : International Conference on Harmonisation (ICH) (1998) (19)
Effect of actinomycin D and guanidine on the formation of a ribonucleic acid polymerase induced by foot-and mouth-disease virus and on the replication of virus and viral ribonucleic acid. (1969) (18)
Some Physico-chemical Properties of two Honey-bee Picornaviruses (1973) (18)
Induced ribonucleic acids in cells infected with vesicular stomatitis virus. (1969) (18)
A study of the level of nucleotide sequence conservation between the RNAs of two types serotypes of foot-and-mouth disease virus. (1980) (18)
WHO Working Group on Characterization of HIV-Related Retroviruses: criteria for characterization and proposal for a nomenclature system. (1987) (18)
A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses. (2005) (18)
In vivo interference in vesicular stomatitis virus infection (1977) (17)
Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination. (2002) (17)
Infection of man by swine vesicular disease virus. (1976) (17)
Vaccines '97 : Molecular approaches to the control of infectious diseases (1997) (17)
Analysis of the secondary structure of the poly(C) tract in foot-and-mouth disease virus RNAs. (1985) (16)
Proteins induced by infection with caliciviruses. (1978) (16)
Vaccines 88: New Chemical And Genetic Approaches to Vaccination : Prevention of AIDS And Other Viral, Bacterial, And Parasitic Diseases (1988) (16)
Foot-and-mouth disease and beyond: vaccine design, past, present and future. (1999) (16)
A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles. (1988) (16)
Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides. (1988) (16)
Relationship of encephalomyocarditis virus to cricket paralysis virus of insects. (1984) (16)
Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation. (1994) (16)
The antigens of vesicular stomatitis virus. II. The presence of two low molecular weight immunogens in virus suspensions. (1966) (16)
An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines. (1991) (15)
Efficacy of rabies vaccine prepared from virus grown in duck embryo. (1970) (15)
Quality of biotechnological products : Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin : International Conference on Harmonisation (ICH) (1998) (15)
A major difference in the strategy of the calici- and picornaviruses and its significance in classification. (1975) (14)
Replication of foot-and-mouth disease virus ribonucleic acid. (1970) (14)
A comparative study of the surface projections of different strains of vesicular stomatitis virus. (1975) (14)
A universal virus inactivant for decontaminating blood and biopharmaceutical products. (1998) (14)
Permanent teratocarcinoma-derived cell lines stabilized by transformation with SV40 and SV40tsA mutant viruses. (1979) (14)
Changes in Specificity and Electrophoretic Mobility of the Precipitating Antibodies present in the Serum of Cattle recovering from Foot-and-Mouth Disease (1959) (14)
A plant virus HIV-1 chimera stimulates antibody that neutralizes HIV-1 (1996) (13)
Vaccines 87 : modern approaches to new vaccines : prevention of AIDS and other viral, bacterial, and parasitic diseases (1987) (13)
The influence of proflavine on the synthesis of foot-and-mouth disease virus. (1960) (13)
Questions concerning the potency of rabies vaccine. (1978) (13)
A β-Globulin Antibody in the Sera of Guinea Pigs and Cattle Infected with Foot-and-Mouth Disease (1960) (12)
Characterization of Kawino Virus, an Entero-like Virus Isolated from the Mosquito Mansonia uniformis (Diptera: Culicidae) (1978) (12)
Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations. (1998) (12)
Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals : viral safety and regulatory aspects Strasbourg, France May 5-6, 1998 (1999) (12)
Structure-Function Relationships in the Picornaviruses (1979) (12)
Synthesis of ribonucleic acid in baby-hamster kidney cells in the presence of actinomycin D. (1967) (12)
Effect of p-Fluorophenylalanine on the Multiplication of Foot-and-Mouth Disease Virus (1961) (11)
Virology: Directory & Dictionary of Animal Bacterial and Plant Viruses (1989) (11)
Foot-and-mouth disease virus (1981) (11)
A study of immunoglobulin M antibody to measles, canine distemper, and rinderpest viruses in sera of patients with subacute sclerosing panencephalitis. (1975) (11)
Replacement, reduction and refinement of animal experiments in the development and control of biological products, Langen, Germany, November 2-4, 1994 (1996) (11)
Fractionation of the virus of foot-and-mouth disease by chromatography on DEAE-cellulose. (1959) (10)
Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production. (1995) (10)
Function of minor polypeptides in foot-and-mouth disease virus and poliovirus. (1994) (10)
Mimicry of viral epitopes with retro-inverso peptides of increased stability. (1996) (10)
WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological substances N°50) : Safety of Biological Products Prepared from Mammalian Cell Culture (1998) (10)
Vaccines 86: New Approaches to Immunization : Developing Vaccines Against Parasitic, Bacterial, and Viral Diseases (1986) (10)
A study of the heterogeneous 37S ribonucleic acid induced by foot-and-mouth-disease virus. (1968) (10)
Variation in foot-and-mouth disease virus isolates in Kenya: an examination of field isolates by T1 oligonucleotide fingerprinting. (1985) (10)
Chromatography of Infective Ribonucleic Acid from Foot-and-mouth Disease Virus on Calcium Phosphate (1963) (9)
Quality of biotechnological products : Derivation and characterisation of cell substrates used for production of biotechnological/biological products : International Conference on Harmonisation (ICH) (1998) (9)
Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus (1980) (9)
Molecular approach to the epidemiology of swine vesicular disease: correlation of variation in the virus structural polypeptides with serological properties (1979) (9)
The development of chemically synthesized vaccines. (1989) (9)
Peptides as the Next Generation of Foot-and-Mouth Disease Vaccines (1985) (9)
Control of foot-and-mouth disease by vaccination. (1999) (9)
Biochemical and biophysical characteristics of vesicular exanthema virus and the viral ribonucleic acid (2005) (8)
Mechanism of infection of pig-kidney cells by foot-and-mouth disease virus (1961) (8)
Effect of Proflavine on the Formation of the Virus of Foot-and-Mouth Disease and its Infective Ribonucleic Acid in Pig Kidney Tissue Culture Monolayers (1959) (8)
The influence of mitomycin C, actinomycin D and ultraviolet light on the replication of the viruses of foot-and-mouth disease and vesicular stomatitis. (1968) (8)
Inhibition of Virus Growth by a Toxic Factor from Asbestos Pad and Cellulose Acetate Membrane Filters (1965) (8)
A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure (2005) (8)
An inactivated baby hamster kidney cell rabies vaccine for use in dogs and cattle. (1971) (8)
Evidence that the envelope protein of flaviviruses encodes determinants of attenuation and virulence. (1990) (7)
The Solution Conformational Features of Two Highly Homologous Antigenic Peptides of Foot‐and‐mouth Disease Virus Serotype A, Variants A and USA, Correlate with their Serological Properties (1996) (7)
Evidence for the type of nucleic acid in African swine fever virus (1966) (7)
Immunization of monkeys with baculovirus recombinant-expressed dengue envelope and NS1 glycoproteins induces partial resistance to challenge with homotypic dengue virus. (1990) (7)
Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde (2005) (7)
Full protection against an immunodepressive viral disease by a recombinant antigen produced in yeast. (1990) (6)
Synthetic peptides as potential vaccines against foot-and-mouth disease. (1990) (6)
The Family Rhabdoviridae General Description and Taxonomy (1987) (6)
The Leeuwenhoek Lecture, 1993. Peptide vaccines: dream or reality? (1994) (6)
Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides (2005) (6)
Immunoelectrophoretic Evidence for the Presence of Two Precipitating Antibodies in Serum following Infection with the Virus of Foot-and-Mouth Disease (1958) (6)
Coinfection of cats with FIV and FeLV affects both quantity and distribution of FIV DNA in various tissues. (1990) (6)
Heat-Labile Complement-Fixing Antigens in the Growth-Cycle of Foot-and-Mouth Disease Virus (1963) (5)
Effect of virus infection on the stability and synthesis of actinomycin-resistant ribonucleic acid in baby-hamster kidney cells. (1967) (5)
Quality of biotechnological products : Analysis of the expression construct in cell lines used for production of r-DNA derived protein products : International Conference on Harmonisation (ICH) (1998) (5)
How do vaccinia-vectored vaccines fit into animal immunization programmes? (1989) (5)
Infective Ribonucleic Acid from the Viruses of Talfan and Teschen Diseases (1960) (5)
Review Lecture - Foot-and-mouth disease – one of the remaining great plagues (1986) (5)
Lymphocyte proliferative responses to dengue virus E and NS1 proteins in BALB/c mice. (1990) (5)
Pertussis vaccine trials : Istituto Superiore di Sanità, Rome, Italy, October 30-November 1, 1995 (1997) (5)
Rabies virus and the problems of rabies vaccination in man. (1976) (5)
Helper T-cell determinants in vaccine design. (1989) (4)
Selection and analysis of protective epitopes on the E2 envelope of Semliki Forest virus. (1990) (4)
Peptide vaccines: fantasy or reality? (1992) (4)
A study of the interference phenomenon in vesicular stomatitis virus replication (2005) (4)
Problems with BHK 21 cells. (1998) (4)
The assay, extraction and storage of infective ribonucleic acid from foot and mouth disease virus. (1966) (4)
Foot-and-mouth disease virus particles contain replicase protein 3 (4)
The importance of antigenic variation in vaccine design. (1994) (4)
Antigenic Variation in Foot-and-Mouth Disease Virus (2002) (4)
Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations. (1998) (4)
Modulation of the immune response to vaccine antigens : University of Bergen, Norway, June 18-21, 1996 (1998) (3)
Human T lymphocyte responses to dengue viruses: recognition of dengue virus proteins by T lymphocytes. (1990) (3)
The Solution Structure of the Immunodominant and Cell Receptor Binding Regions of Foot‐and‐mouth Disease Virus Serotype A, Variant A (1996) (3)
Sequence identification of antigenic variants in plaque isolates of foot-and-mouth disease virus. (1995) (3)
Peptides as viral vaccines: lessons from experiments with foot-and-mouth disease virus (1991) (3)
Physico-chemical characterisation of rinderpest virus (2005) (3)
Achievements in genetic engineering and their influence on the control and prevention of animal diseases. (1983) (3)
New approaches to vaccine development: memorandum from a WHO meeting. (1985) (3)
Correlations between the solution conformation and serological properties of FMDV variants (1991) (3)
Alternatives to animals in the development and control of biological products for human and veterinary use : London Zoo, London, U.K. September 24-26, 1998 (1999) (3)
Characterization of antibody responses induced by different synthetic adjuvants to the Plasmodium falciparum major merozoite surface precursor protein, gp 195. (1990) (3)
Synthetic Peptides as Immunogens (1988) (2)
A universal virus inactivant for decontaminating blood and biopharmaceutical products. (1999) (2)
Genetically engineered vaccines: problems and promises. (1984) (2)
Vaccination against foot-and-mouth disease: Past, present and future (1985) (2)
Protective immunity against Newcastle disease virus induced by fowl poxvirus recombinants. (1990) (2)
Biological characterization and assay of cytokines and growth factors : National Institute for Biological Standards and Control, Potters Bar, Herts., U.K. September 10-12, 1997 (1999) (2)
Structure-function relationships in foot-and-mouth disease virus. (1972) (2)
The potential of retro-inverso peptides as synthetic vaccines. (1998) (2)
DNA Technology and Vaccines (1994) (2)
Six HIV-1 gp120-specific monoclonal antibodies exhibit two mechanisms of neutralization: Inhibition of attachment to the CD4 receptor is not one of them (1996) (2)
Cloning and Expression of Foot and Mouth Disease Virus Genes (1985) (2)
Erythrocyte rosetting and endothelial cytoadherence in Plasmodium falciparum malaria: implications for vaccine development. (1990) (2)
Rabies vaccines for animals and man (1976) (2)
From Jenner to genes--the next generation of virus vaccines. (1987) (2)
Ribonucleic acid synthesis in rinderpest virus infected cells (2005) (2)
The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus. (1976) (2)
Prospects for a Synthetic Foot-and-Mouth Disease Vaccine (1986) (1)
Development of therapeutic cancer vaccines : Los Angeles Airport Renaissance Hotel, California, USA, April 27-29, 2004 (2004) (1)
Virology (1989) (1)
Immune recognition of protein antigens : proceedings of a Royal Society discussion meeting held on 6 and 7 July 1988 (1989) (1)
Physico-chemical procedures for the characterization of vaccines : les Pensiéres, Veyrier-du--Lac, France December 1-3, 1999 (2000) (1)
Development and clinical progress of DNA vaccines : Paul-Ehrlich-Institut, Langen, Germany October 6-8, 1999 (2000) (1)
Thirty years of biochemical work on foot and mouth disease virus at the Pirbright Institute. (1986) (1)
Simian virus 40 (SV40): a possible human polyomavirus. Natcher Auditorium, NIH, Bethesda, Maryland, USA, January 27 and 28, 1997. (1998) (1)
New approaches to stabilisation of vaccines potency : WHO Headquarters, Geneva, May 29-31, 1995 (1996) (1)
Vaccination today and tomorrow (1995) (1)
Chemical basis of antigenic variation in foot-and-mouth-disease virus. (1984) (1)
Recombinant Sub-Unit and Peptide Viral Vaccines (1989) (1)
Looking-glass land (1989) (1)
A molecular approach to the diagnosis of virus infections. (1981) (1)
The pathogenetic aspects of measles virus infection: memorandum from a WHO meeting. (1994) (1)
Laboratory correlates of immunity to influenza--A reassessment : University of Bergen, Bergen, Norway, 2-3 May, 2002, proceedings of a scientific workshop (2003) (1)
RABIES VIRUS AND LABORATORY REGULATIONS (1981) (1)
Synthetic Peptides and Purified Antigens as Vaccines (1994) (1)
New approaches in viral vaccine development. (1990) (1)
Problems with BHK 21 cells : Safety of Biological Products Prepared from Mammalian Cell Culture (1998) (1)
The Antigens of Vesicular Stomatitis Virus (1966) (1)
Antigenic relationships of human and animal rotaviruses as determined by antisera to baculovirus-recombinant expressed VP4 proteins. (1990) (1)
MOLECULAR BASIS OF ANTIGENIC VARIATION IN THE PICORNAVIRUSES (1980) (1)
Insertion of cellular sequences in the genome of a togavirus. (1990) (1)
Molecular basis of antigenicity and attenuation of a flavivirus: tick-borne encephalitis virus. (1990) (1)
Inactivation of viruses by aziridines. (2000) (1)
Expression of antigenically active dengue-1 virus proteins using recombinant baculoviruses. (1990) (1)
Recombinant vaccine against coccidiosis: isolation and properties of a fusion protein. (1990) (1)
Comments on immunology of foot-and-mouth disease in swine. (1972) (0)
Cross-reactions of multiple sclerosis IgM with measles, rinderpest and canine distemper (1974) (0)
A model for in vitro development of live, recombinant alphavirus vaccines. (1990) (0)
Rabies virus and laboratory regulations. (1981) (0)
A divided genome in Nodamura virus 373 (0)
Modeling Biologically Relevant Peptides Using Circular Dichroism with Synchrotron Radiation and High-Temperature Molecular Dynamics (1994) (0)
A celebration of 50 years of progress in biological standardization and control at WHO. WHO Headquarters, Geneva, 25-27 October 1998. Proceedings of a symposium organized and sponsored by the International Association for Biologicals (IABS) and the World Health Organization (WHO). (1999) (0)
Preclinical and clinical development of new vaccines, Institut Pasteur, Paris, France, 27-28 May 1997. (1998) (0)
Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins. (1998) (0)
Consistent inhibition of the growth of BLV in sheep inoculated with the vaccinia-retrovirus env gene recombinant. (1990) (0)
Classification and nomenclature of viruses: summary of decisions of the International Committee on Taxonomy of viruses, Sendai (Japan) September 1984 (1986) (0)
The eradication of foot-and-mouth disease: a parallel problem. (2001) (0)
Advancing science and elimination of the use of laboratory animals for development and control of vaccines and hormones : Jaarbeurs Congress Centre, Utrecht, The Netherlands November 12-14, 2001 (2002) (0)
A study of immunoglobulin M antibody to measles, canine distemper and rinderpest viruses in sera of patients with subacute sclerosing panencephalitis (1974) (0)
Genetic stability and recombinant product consistency : Annecy, France July 8-9, 1993 (1994) (0)
Designing future vaccines. (1991) (0)
Reaction of glutaraldehyde with food-and-mouth disease virus. (1973) (0)
Molecule of deoxyribonucleic acid comprising a sequence of nucleotides corresponding to the protein of FMDV fever, its production process and resulting vaccine (1981) (0)
Temperature-sensitive RNA polymerase mutants of a picornavfrus ( foot-and-mouth disease virus / conditional-lethal isoelectric focusing / reversion / thermal inactivation of transcription ) (0)
Abstracts of papers presented at the 1994 meeting on molecular approaches to the control of infectious diseases, October 5-October 9, 1994 (1994) (0)
Stabilising oral poliovaccine at high ambient temperatures. (1995) (0)
Current Status and Potential of Foot-and-Mouth Disease Vaccines (1992) (0)
Virological safety aspects of plasma derivatives : cannes(France) November 3-6, 1992 (1993) (0)
Recombinant vectors in vaccine development : Albany NY, USA, May 23-26, 1993 (1994) (0)
Safety of biological products prepared from mammalian cell culture : conference Centre of the Marcel-Mérieux Foundation, Les Pensières, Veyrier-du-Lac, Annecy, France, September 29-October 1, 1996 (1998) (0)
Foreword: One Hundred Years of Foot-and-Mouth Disease (1999) (0)
Erratum: Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions (Journal of Virology (1994) 70:6 (4045-4052)) (1996) (0)
panencephalitis . subacute sclerosing viruses in sera of patients with distemper , and rinderpest antibody to measles , canine A study of immunoglobulin M (0)
The antigenic region of the coat protein of the O subtypes of foot and mouth disease virus (1984) (0)
Advances in transfusion safety. San Francisco, CA, USA, March 18-20, 1999. (2000) (0)
Live recombinant adenovirus expressing SIV Gag protein as an immunogen in mice (1997) (0)
Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology. (1987) (0)
Peptides as Potential Vaccines Against Foot and Mouth Disease (1985) (0)
PEPSCAN-based amino acid modifications of a Plasmodium falciparum pfs25 peptide sequence substantially increase reactivity with transmission-blocking monoclonal antibodies. (1990) (0)
Control of foot-and-mouth disease by vaccination. (2003) (0)
Development of specifications for biotechnology pharmaceutical products : Hyatt Regency, San Francisco CA, USA, May 2-3, 1996 (1997) (0)
Genetic engeneering and foot and mouth disease: -EN- -FR- -ES- (1983) (0)
Chemical basis for variation in the major antigenic site elicting neutralizing antibodies in foot-and-mouth disease virus (1984) (0)
Classification et nomenclature des virus: Résumé des décisions du Comité international de Taxonomie des Virus, SENDAÏ (Japon), septembre 1984 (1986) (0)
Vaccines 90: modern approaches to new vaccines including prevention of AIDS: vaccines 90. (1990) (0)
A quarter of a century in foot-and-mouth disease research. (2010) (0)
Removal oftheGenome-Linked Protein ofFoot-and-Mouth Disease Virus byRabbit Reticulocyte Lysate (1981) (0)
Inactivated influenza vaccines prepared in cell culture : National Institute for Biological Standards and Control, Potters Bar, Herts., U.K. September 26-27, 1997 (1999) (0)
Structure—Serologic Relationships of the Immunodominant Site of Foot-and-Mouth Disease Virus (1994) (0)
Characterization of biotechnology pharmaceutical products : Washington D.C., USA December 11-13, 1995 (1998) (0)
Process validation for manufacturing of biologics and biotechnology products : Berlin Hilton Hotel, Berlin, Germany, 6-7 September, 2001 (2003) (0)
Abstracts of papers presented at the 1985 Meeting on Modern Approaches to Vaccines, September 11-September 15, 1985 (1985) (0)
The newer vaccines. (1985) (0)
THE CHEMICAL NATURE OF ANTIVIRAL SEROTYPE SPECIFICITY (1983) (0)
Viral safety and evaluation of viral clearance from biopharmaceutical products : Natcher Conference Center, Bethesda, Maryland, USA, June 14-16, 1995 (1996) (0)
Abstracts of papers presented at the 1995 Meeting on Molecular Approaches to the Control of Infectious Diseases, September 13-September 17, 1995 (1995) (0)
Structure of VP1 coat protein of foot and mouth disease virus (1987) (0)
A genetically engineered marker vaccine and a companion diagnostic test for the control of pseudorabies virus. (1990) (0)

This paper list is powered by the following services:

Other Resources About Fred Brown

en.wikipedia.org

What Schools Are Affiliated With Fred Brown ?

Fred Brown is affiliated with the following schools:

Fred Brown 's Academic­Influence.com Rankings